Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1989 1
2000 1
2008 1
2016 1
2017 2
2018 1
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Stability study of oral pediatric idebenone suspensions.
Schlatter J, Bourguignon E, Majoul E, Kabiche S, Balde IB, Cisternino S, Fontan JE. Schlatter J, et al. Among authors: bourguignon e. Pharm Dev Technol. 2017 Mar;22(2):296-299. doi: 10.1080/10837450.2016.1231811. Epub 2016 Sep 21. Pharm Dev Technol. 2017. PMID: 27583702
Trance and shamanism: what's in a name?
Bourguignon E. Bourguignon E. J Psychoactive Drugs. 1989 Jan-Mar;21(1):9-15. doi: 10.1080/02791072.1989.10472138. J Psychoactive Drugs. 1989. PMID: 2656955 Review.
Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).
Sunhary De Verville PL, Stubbs B, Etchecopar-Etchart D, Godin O, Andrieu-Haller C, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, Dorey JM, Dubertret C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Pignon B, Rey R, Urbach M, Llorca PM, Schürhoff F, Lançon C, Boyer L, Fond G; Collaborators: the FACE-S. Z. (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Sunhary De Verville PL, et al. Eur Arch Psychiatry Clin Neurosci. 2022 Oct;272(7):1273-1282. doi: 10.1007/s00406-022-01384-x. Epub 2022 Apr 20. Eur Arch Psychiatry Clin Neurosci. 2022. PMID: 35441901
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
Overlap and Mutual Distinctions Between Clinical Recovery and Personal Recovery in People With Schizophrenia in a One-Year Study.
Dubreucq J, Gabayet F, Godin O, Andre M, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Coulon N, D'Amato T, Dorey JM, Dubertret C, Faraldo M, Laouamri H, Leigner S, Lancon C, Leboyer M, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Pignon B, Schorr B, Urbach M, Schürhoff F, Szoke A; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Groups; Fond G, Berna F. Dubreucq J, et al. Schizophr Bull. 2022 Mar 1;48(2):382-394. doi: 10.1093/schbul/sbab114. Schizophr Bull. 2022. PMID: 34718808 Free PMC article.
Usage Intensity of a Relapse Prevention Program and Its Relation to Symptom Severity in Remitted Patients With Anxiety and Depression: Pre-Post Study.
Krijnen-de Bruin E, Muntingh AD, Bourguignon EM, Hoogendoorn A, Maarsingh OR, van Balkom AJ, Batelaan NM, van Straten A, van Meijel B. Krijnen-de Bruin E, et al. Among authors: bourguignon em. JMIR Ment Health. 2022 Mar 16;9(3):e25441. doi: 10.2196/25441. JMIR Ment Health. 2022. PMID: 35293876 Free PMC article.
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.
Garosi A, Sunhary de Verville PL, Etchecopar-Etchart D, Richieri R, Godin O, Schürhoff F, Berna F, Aouizerate B, Capdevielle D, Chereau I, Clauss-Kobayashi J, Dorey JM, Dubertret C, Coulon N, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Szoke A, Urbach M, Leboyer M, Llorca PM, Lançon C, Boyer L, Fond G; Collaborators : the FACE-SZ (Fonda Mental Academic Centers of Expertise for Schizophrenia) group. Garosi A, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Jun;273(4):825-837. doi: 10.1007/s00406-022-01449-x. Epub 2022 Jul 19. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 35852617
Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Leignier S, Llorca PM, Lançon C, Mallet J, Passerieux C, Pignon B, Rey R, Schürhoff F, Swendsen J, Urbach M, Szöke A, Godin O, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group. Misdrahi D, et al. Transl Psychiatry. 2023 Nov 7;13(1):341. doi: 10.1038/s41398-023-02640-x. Transl Psychiatry. 2023. PMID: 37935695 Free PMC article.
13 results